| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |